P
USRE37447EExpiredUtilityPatentIndex 52

Modified Kluyveromyces yeasts, their preparation and use

Assignee: AVENTIS PHARMA SAPriority: Jun 25, 1992Filed: Jun 23, 1993Granted: Nov 13, 2001
Est. expiryJun 25, 2012(expired)· nominal 20-yr term from priority
Inventors:FLEER REINHARDFOURNIER ALAINYEH PATRICE
C12N 9/48C12N 9/60C12N 15/815
52
PatentIndex Score
1
Cited by
11
References
13
Claims

Abstract

The present invention concerns yeasts of the genus Kluyveromyces having one or more genetic modifications of at least one gene coding for a protease, said gene reducing or modifying the proteolytic actively of said yeasts, as well as their use as a cellular host for the secretion of recombinant proteins.

Claims

exact text as granted — not AI-modified
We claim:  
     
       1. A Kluyverornyces  Kluyveromyces yeast comprising a genetic modification in its PRA1, PRB1 or PRC1 gini  gene, wherein said modification results in loss of protease activity encoded by said gene. 
     
     
       2. The Kluyverormyces yeast according to claim  1 , wherein the modification is in 
       a) protein coding region of said gene;  
       b) a region responsible for transcriptional regulation of said gene; or  
       c) both a protein coding region of said gene and a region responsible for transcriptional regulation of said gene.  
     
     
       3. The Kluyveromyces yeast according to claim  1 , selected from the group consisting of K. lactis, K. fragilis, K, drosophilarum, and K. waltii. 
     
     
       4. A process for preparing the Kluyveromyces yeast of claim  1  comprising replacing all or part of said gene with a modified version thereof. 
     
     
       5. A Kluyveromyces yeast comprising a genetic modification in its PRA1, PRB1, or PRC1 gene, wherein said modification results in loss of protease activity encoded by said gene, and an exogenous DNA sequence comprising a nucleic acid sequence encoding at least one protein. 
     
     
       6. The Kluyveromyces yeast according to claim  5 , wherein the exogenous DNA sequence further comprises a region for initiation of transcription and translation operably linked to the nucleic acid sequence encoding the at least one protein. 
     
     
       7. The Kluyveromyces yeast according to claim  5 , wherein the exogenous sequence comprises a region encoding an exporting sequence for secretion of the protein. 
     
     
       8. The Kluyveromyces yeast according to claim  5 , wherein the exogenous DNA sequence is part of an autonomously replicating vector or is integrated into a chromosome. 
     
     
       9. A process for producing recombinant proteins comprising culturing the Kluyverornyces  Kluyveromyces yeast of claim  5  under conditions for expression of said exogenous DNA sequence. 
     
     
       10. A process for producing recombinant proteins comprising culturing the Kluyveromyces yeast of claim  6  under conditions for expression of said exogenous DNA sequence. 
     
     
       11. A process for producing recombinant proteins comprising culturing the Kluyverormyces yeast of claim  7  under conditions for expression of said exogenous DNA sequence. 
     
     
       12. The Kluyveromyces yeast according to claim  5 , wherein the exogenous DNA sequence encodes a protein of pharmaceutical interest. 
     
     
       13. A process for producing recombinant proteins comprising culturing the Kluyveromyces yeast of claim  12  under conditions for expression of said exogenous DNA sequence.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.